ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.041,87
0,12%
S&P 500
5.431,60
0,00%
Dow Jones
38.589,16
0,00%
Euro vs US Dollar
1,07136
0,11%
Bitcoin
65.560,12
-1,62%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. NexGel Inc (NXGLW)

  7. NexGel Inc (NXGLW) News

NXGLW

NexGel (NXGLW)

NexGel Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NXGLW
DatumZeitQuelleÜberschriftSymbolFirma
13/06/202423h19Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:NXGLWNexGel Inc
11/06/202414h40GlobeNewswire Inc.NEXGEL and STADA Partner to Launch Leading European DAO Enzyme Supplement, Histasolv, in North AmericaNASDAQ:NXGLWNexGel Inc
20/05/202412h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXGLWNexGel Inc
16/05/202415h00GlobeNewswire Inc.NEXGEL Acquires International Beauty Brand, Silly GeorgeNASDAQ:NXGLWNexGel Inc
13/05/202423h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NXGLWNexGel Inc
13/05/202423h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NXGLWNexGel Inc
13/05/202422h05GlobeNewswire Inc.NEXGEL Reports First Quarter 2024 Revenue of $1.27 Million, an Increase of 104% Year-Over-YearNASDAQ:NXGLWNexGel Inc
09/05/202414h00GlobeNewswire Inc.NEXGEL to Report First Quarter 2024 Financial Results on May 13thNASDAQ:NXGLWNexGel Inc
06/05/202422h05GlobeNewswire Inc.NEXGEL to Present at the Aegis Capital Virtual Conference on May 9, 2024NASDAQ:NXGLWNexGel Inc
18/04/202414h00GlobeNewswire Inc.NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024NASDAQ:NXGLWNexGel Inc
01/04/202413h50GlobeNewswire Inc.NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-YearNASDAQ:NXGLWNexGel Inc
27/03/202414h00GlobeNewswire Inc.NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to HolidayNASDAQ:NXGLWNexGel Inc
21/03/202414h00GlobeNewswire Inc.NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28thNASDAQ:NXGLWNexGel Inc
04/03/202414h30GlobeNewswire Inc.NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12thNASDAQ:NXGLWNexGel Inc
21/02/202422h05GlobeNewswire Inc.NEXGEL Announces $975,000 Registered Direct Offering Led by InsidersNASDAQ:NXGLWNexGel Inc
18/01/202415h00GlobeNewswire Inc.NEXGEL to Present at The Microcap Conference, January 30th through February 1stNASDAQ:NXGLWNexGel Inc
09/01/202414h30GlobeNewswire Inc.NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024NASDAQ:NXGLWNexGel Inc
11/12/202314h00GlobeNewswire Inc.NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North AmericaNASDAQ:NXGLWNexGel Inc
05/12/202314h00GlobeNewswire Inc.NEXGEL Acquires Kenkoderm Psoriasis Skincare LineNASDAQ:NXGLWNexGel Inc
13/11/202322h05GlobeNewswire Inc.NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-YearNASDAQ:NXGLWNexGel Inc
02/11/202314h00GlobeNewswire Inc.NEXGEL to Report Third Quarter 2023 Financial Results on November 13thNASDAQ:NXGLWNexGel Inc
30/10/202313h00GlobeNewswire Inc.NEXGEL Secures Supply Agreement with AbbVieNASDAQ:NXGLWNexGel Inc
26/09/202315h49GlobeNewswire Inc.NEXGEL to Participate in the LD Micro Main Event XVI on October 3rdNASDAQ:NXGLWNexGel Inc
14/08/202322h05GlobeNewswire Inc.NEXGEL Reports Second Quarter 2023 Record Revenue of $1.17 Million, an Increase of 108% Year-Over-YearNASDAQ:NXGLWNexGel Inc
02/08/202315h00GlobeNewswire Inc.NEXGEL to Report Second Quarter 2023 Financial Results on August 14thNASDAQ:NXGLWNexGel Inc
19/07/202315h10GlobeNewswire Inc.NEXGEL Partners with Enigma Health to Distribute its Leading Products in Retail Stores throughout North AmericaNASDAQ:NXGLWNexGel Inc
15/06/202315h00GlobeNewswire Inc.NEXGEL to Participate in Maxim Group’s Virtual Healthcare Conference on June 20thNASDAQ:NXGLWNexGel Inc
24/05/202315h00GlobeNewswire Inc.NEXGEL to Participate in the LD Micro Invitational XIII on June 6thNASDAQ:NXGLWNexGel Inc
15/05/202322h05GlobeNewswire Inc.NEXGEL Reports First Quarter 2023 Financial ResultsNASDAQ:NXGLWNexGel Inc
09/05/202315h15GlobeNewswire Inc.NEXGEL to Report First Quarter 2023 Financial Results on May 15thNASDAQ:NXGLWNexGel Inc
 Showing the most relevant articles for your search:NASDAQ:NXGLW

Kürzlich von Ihnen besucht

BIT
I08824
Intesa Sanpaolo
USOTC
MKGP
Maverick Energy (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten